Novo Nordisk receives subpoena in the US

BAGSVAERD, DENMARK--(Marketwire - February 16, 2011) -

The office of the US Attorney for the District of Massachusetts has served
Novo
Nordisk with a subpoena calling for the production of documents regarding
potential criminal offences relating to the company's marketing and
promotion
practices for the following products: NovoLog®, Levemir®, and
Victoza®. Novo
Nordisk will cooperate with the US Attorney in this investigation.

At this time, Novo Nordisk cannot determine or predict the outcome of this
matter or assess the consequences thereof. In addition, the company cannot
predict how long the investigation will take or when it will be able to
provide
additional information.